Document:

[ EXHIBIT 4.1 -  PHCC 2003 BENEFIT PLAN ]

                   THE 2003 STOCK, OPTION AND RESTRICTED STOCK
                                  BENEFIT PLAN
                                       OF
                            PERFECT HEALTHCARE CORP.

Perfect Healthcare Corp., a Nevada corporation (the "Company"), hereby adopts
The 2003 Stock, Option and Restricted Stock Benefit Plan of Perfect Healthcare
Corp. (the "Plan") this 1st day of July 2003. Under the Plan, the Company may
issue stock, or grant options to acquire the Company's common stock, par value
$0.001 (the "Stock"), from time to time to employees of the Company or its
subsidiaries, all on the terms and conditions set forth herein ("Benefits"). In
addition, at the discretion of the Board of Directors, Benefits may from time to
time be granted under this Plan to other individuals, including consultants or
advisors, who contribute to the success of the Company or its subsidiaries but
are not employees of the Company or its subsidiaries, provided that bona fide
services shall be rendered by consultants and advisors and such services must
not be in connection with the offer or sale of securities in a capital-raising
transaction. Furthermore, no stock may be issued, or option granted, under the
benefit plan to consultants, advisors, or other persons who directly or
indirectly promote or maintain a market for the Company's securities.

1. Purpose of the Plan. The Plan is intended to aid the Company in maintaining
and developing a management team, attracting qualified officers, employees,
consultants and key advisors capable of contributing to the future success of
the Company, and rewarding those individuals who have contributed to the success
of the Company. The Company has designed this Plan to aid it in retaining the
services of executives and employees and in attracting new personnel when needed
for future operations and growth and to provide such personnel with an incentive
to remain employees of the Company, to use their best efforts to promote the
success of the Company's business, and to provide them with an opportunity to
obtain or increase a proprietary interest in the Company. It is also designed to
permit the Company to reward those individuals who are not employees of the
Company but who management perceives to have contributed to the success of the
Company or who are important to the continued business and operations of the
Company. The above goals will be achieved through the granting of Benefits.

2. Administration. The Plan shall be administered by the Board of Directors of
the Company (the 'Board') which shall keep the minutes of its proceedings with
regard to the Plan and all records, documents, and data pertaining to its
administration of the Plan. A majority of the members of the Board shall
constitute a quorum for the transaction of business, and the vote of a majority
of those members present at any meeting shall decide any question brought before
that meeting. In addition, the Board may take any action otherwise proper under
the Plan by the affirmative vote, taken without a meeting, of a majority of its
members. Any decision or determination reduced to writing and signed by a
majority of the members shall be as effective as if it had been made by a
majority vote at a meeting properly called and held. All questions of
interpretation and application of the Plan shall be subject to the determination
of the Board. The actions of the Board in exercising all of the rights, powers
and authorities set out in this Plan, when performed in good faith and in its
sole judgment, shall be final, conclusive, and binding on the parties.

3. Shares of Stock Subject to this Plan. A total of Five Million (5,000,000)
Shares of Common Stock may be subject to, or issued pursuant to, Benefits
granted under this Plan. If any right to acquire Stock granted under this Plan
is exercised by the delivery of shares of Stock or the relinquishment of rights
to shares of Stock, only the net shares of Stock issued (the shares of stock
issued less the shares of Stock surrendered) shall count against the total
number of shares reserved for issuance under the terms of this Plan.

4. Reservation of Stock on Granting of Option. At the time any Option is granted
under the terms of this Plan, the Company will reserve for issuance the number
of shares of Stock subject to such Option until it is exercised or expires. The
Company may reserve either authorized but unissued shares or issued shares
reacquired by the Company (treasury stock).

5. Eligibility. The Plan Administrators may grant Benefits to employees,
officers, and directors of the Company and its subsidiaries, as may be existing
from time to time, and to other individuals who are not employees of the Company
or its subsidiaries, including consultants and advisors, provided that such
consultants and advisors render bona fide services to the Company or its
subsidiaries and such services are not rendered in connection with the offer or
sale of securities in a capital-raising transaction, or for establishing,
maintaining or promoting a public market for the Company's securities. In any
case, the Plan Administrators shall determine, based on the foregoing
limitations and the Company's best interests, which employees, officers,
directors, consultants and advisors are eligible to participate in this Plan.
Benefits shall be in the amounts, and shall have the rights and be subject to
the restrictions, as may be determined by the Plan Administrators, all as may be
within the provisions of this Plan.

6. Authority to Grant Stock Awards. The Board in its discretion and subject to
the provisions of the Plan may, from time to time, grant to eligible individuals
of the Company Stock Awards. The Board may award and issue shares of Common
Stock under the Plan in fulfillment of such Stock Awards. Stock Awards may be
made in lieu of cash compensation or as additional compensation. Stock Awards
may also be made pursuant to performance-based goals established by the Board.

Subject only to any applicable limitations set forth in the Plan, the number of
shares of Common Stock covered by any Stock Award shall be determined by the
Board.

7.  Stock Awards.

(a) Awards in Lieu of Compensation. The Board may grant Common Stock to an
Eligible Individual under the Plan, without any payment by the individual, in
lieu of certain cash compensation or as additional compensation. The Stock Award
is subject to appropriate tax withholding. After compliance with the tax
withholding requirements, a stock certificate shall be issued to the individual
recipient of the Stock Award. The certificate shall bear such legend, if any, as
the Board determines is reasonably required by applicable law. Prior to receipt
of a Stock Award, the individual must comply with appropriate requests of the
Board to assure compliance with all relevant laws.

(b) Performance Based Awards. The Board may award shares of Common Stock,
without any payment for such shares, to designated individuals if specified
performance goals established by the Board are satisfied. The designation of an
employee eligible for a specific performance-based Stock Award shall be made by
the Board in writing prior to the beginning of the twelve month period for which
the performance is measured. The Board shall establish the number of shares to
be issued to a designated employee if the performance goal is met. The Board
must certify in writing that a performance goal has been met prior to issuance
of any certificate for a performance-based Stock Award to any employee. If the
Board certifies the entitlement of an employee to the performance-based Stock
Award, the certificate shall be issued to the employee as soon as
administratively practicable, and subject to other applicable provisions of the
Plan, including but not limited to, all legal requirements and tax withholding.
Performance goals determined by the Board may be based on specified increases in
net profits, stock price, Company or segment sales, market share, earnings per
share, and/or return on equity.

8. Option Awards.

     a. Term of Options issued as Benefits and Certain Limitations on Right to
     Exercise.

          i. Each Option issued as a benefit hereunder ("Option") shall have its
          term established by the Plan Administrators at the time the Option is
          granted.

          ii. The term of the Option, once it is granted, may be reduced only as
          provided for in this Plan and under the express written provisions of
          the Option.

          iii. Unless otherwise specifically provided by the written provisions
          of the Option or required by applicable disclosure or other legal
          requirements promulgated by the Securities and Exchange Commission
          ("SEC"), no participant of this Plan or his or her legal
          representative, legatee, or distributee will be, or shall be deemed to
          be, a holder of any shares subject to an Option unless and until such
          participant exercises his or her right to acquire all or a portion of
          the Stock subject to the Option and delivers the required
          consideration to the Company in accordance with the terms of this Plan
          and then only as to the number of shares of Stock acquired. Except as
          specifically provided in this Plan or as otherwise specifically
          provided by the written provisions of the Option, no adjustment to the
          exercise price or the number of shares of Stock subject to the Option
          shall be made for dividends or other rights for which the record date
          is prior to the date on which the Stock subject to the Option is
          acquired by the holder. iv. Options shall vest and become exercisable
          at such time or times and on such terms as the Plan Administrators may
          determine at the time of the grant of the Option.

          v. Options may contain such other provisions, including further lawful
          restrictions on the vesting and exercise of the Options as the Plan
          Administrators may deem advisable.

          vi. In no event may an Option be exercised after the expiration of its
          term.

          vii. Options shall be non-transferable, except by the laws of descent
          and distribution.

          viii. No person shall be granted in any calendar year the right to
          purchase more than 300,000 shares.

b. Exercise Price. The Plan Administrators shall establish the exercise price
payable to the Company for shares to be obtained pursuant to Options, which
exercise price may be amended from time to time as the Plan Administrators shall
determine.

c. Payment of Exercise Price. The exercise of any Option shall be contingent on
receipt by the Company of the exercise price paid in either cash, certified
check or personal check payable to the Company.

d. Termination of Employment. Upon termination of an Option holder's active
employment with the Corporation and its subsidiaries for any reason (including
illness or disability), the Option and rights thereunder shall terminate on the
date of termination of employment. The Board has the discretion in the event the
Option holder takes a leave of absence from the Corporation and its subsidiaries
for personal reasons or for military service to take such action in respect of
the Option as the Board may deem appropriate, including extending the time
following termination of active employment during which the Option holder is
entitled to purchase the shares of Common Stock subject to his Option. If an
Option holder's employment with the Corporation and its subsidiaries terminates
by reason of death or retirement pursuant to normal Corporation policies, the
retired employee or the personal representative of the deceased employee may
elect to exercise the Option at any time following the termination of the Option
holder's employment. In no event may any Option be exercised after the
expiration of its term.

9. Registration. The Company may, but shall not be obligated to, register any
securities covered by a Stock Award, or securities underlying an Option award,
pursuant to the Securities Act of 1933 (as now in effect or as hereafter
amended) and, in the event any shares are registered, the Company may remove any
legend on certificates representing these shares. The Company shall not be
obligated to take any other affirmative action in order to cause the Stock Award
to comply with any law or regulation of any governmental authority.

10. Withholding. If the grant of a Benefit hereunder, or exercise of an Option
given as a Benefit is subject to withholding or other trust fund payment
requirements of the Internal Revenue Code of 1986, as amended (the "Code"), or
applicable state or local laws, the Company will initially pay the Grantee's
liability and will be reimbursed by Grantee no later than six months after such
liability arises and Grantee hereby agrees to such reimbursement terms.

11. Dilution or Other Adjustment. The shares of Stock subject to this Plan and
the exercise price of outstanding Options are subject to proportionate
adjustment in the event of a stock dividend on the Stock or a change in the
number of issued and outstanding shares of Stock as a result of a stock split,
consolidation, or other recapitalization. The Company, at its option, may adjust
the Options, issue replacements, or declare Options void.

12. Employment Obligation. The granting of any Stock Award shall not impose upon
the Company any obligation to employ or continue to employ any grantee; and the
right of the Company to terminate the employment of any officer or other
employee shall not be diminished or affected by reason of the fact that a Stock
Award has been granted to him.

13. Expiration and Termination of this Plan. This Plan may be abandoned or
terminated at any time by the Plan Administrators except with respect to any
Options then outstanding under this Plan. This Plan shall otherwise terminate on
the earlier of the date that is five years from the date first appearing in this
Plan or the date on which the Fifteen Millionth share is issued hereunder.

14. Amendment of this Plan. This Plan may not be amended more than once during
any six month period, other than to comport with changes in the Code or the
Employee Retirement Income Security Act or the rules and regulations promulgated
thereunder. The Plan Administrators may modify and amend this Plan in any
respect.

ATTEST:

/s/ Antoine Jorjour
-------------------------------------
President, CEOForm of Investment Agreement between the Company and certain purchasers

 Exhibit 4.2 
  
 INVESTMENT AGREEMENT 
  
 THIS INVESTMENT AGREEMENT, dated as of [                ,
2003] (this “Agreement”), is entered into by and between ACCLAIM ENTERTAINMENT INC., a Delaware corporation (the “Company”), and those persons named on Schedule 1 hereto (together, the
“Purchasers”). 
  
 RECITALS: 
  
 WHEREAS, the Company and the Purchasers are executing and delivering
this Agreement in reliance upon the exemptions from registration provided by Regulation D (“Regulation D”) promulgated by the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933,
as amended (the “Securities Act”), and/or Section 4(2) of the Securities Act; and 
  
 WHEREAS, the Purchasers wish to purchase from the Company, and the Company wishes to issue and sell to the Purchasers, for an aggregate purchase
price of $                     (the “Purchase Price”), upon the terms and conditions set forth in this Agreement, a total of
                     shares (the “Shares”) of the Company’s common stock, par value $.02 per share (the “Common
Stock”) and warrants (the “Warrants”) to purchase of a total of                      shares of Common Stock; and

  
 WHEREAS, in connection with the consummation of the
transactions contemplated by this Agreement, the parties hereto are also entering into, of even date herewith, a registration rights agreement (the “Registration Rights Agreement”) and a warrant agreement (the “Warrant
Agreement”). This Agreement, together with the Registration Rights Agreement and the Warrant Agreement are hereinafter collectively referred to as the “Transaction Documents”; and 
  
 NOW, THEREFORE, in consideration of the premises and the mutual
covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
  
 AGREEMENTS: 
  
 1.    AGREEMENT TO PURCHASE; CLOSING 
  
 (a) Purchase of Shares. Subject to the terms and conditions set forth herein, the Company hereby agrees to issue and sell to each of the
Purchasers, and each Purchaser hereby agrees to purchase from the Company for the Purchase Price, such number of Shares and Warrants at the Closing (as such term is defined in Section 1(b) hereof) as is listed opposite the name of such Purchaser on
Schedule 1 hereto. 
  
 (b) Closing. The closing (the
“Closing”) of the purchase and sale of the Shares will take place at the offices of the Company, One Acclaim Plaza, Glen Cove, New York 11542 on
                    , 2003, or at such other place and time as may be mutually agreed by the Purchasers and the Company. The date of the
Closing is referred to herein as the “Closing Date.” At the Closing, the Company will deliver to the Purchasers the applicable Shares and Warrants 

 purchased as set forth on Schedule 1 hereto, in exchange for payment by the Purchasers of the Purchase Price, by
wire transfer of immediately available funds payable to the Company. The Shares and the Warrants shall be registered in each Purchaser’s name or the name of its nominee(s) in such denominations as the Purchasers shall request pursuant to
instructions delivered to the Company prior to the Closing. 
  
 2.    REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS; ACCESS TO INFORMATION; INDEPENDENT INVESTIGATION 
  
 Each of the Purchasers severally represents and warrants to the Company as follows: 
  
 (a) Accredited Investors. Such Purchaser is: (i) experienced in making
investments of the kind contemplated by this Agreement; (ii) able, by reason of business and financial experience, to protect its own interests in connection with the transactions contemplated by this Agreement; (iii) able to afford the entire loss
of its investment in the Shares and the Warrants; (iv) an “accredited investor” as that term is defined in Rule 501(a) of Regulation D; and (v) not a broker-dealer or an affiliate of a broker-dealer as such terms are defined in the
Securities Exchange Act of 1934, as amended (the “Exchange Act”). 
  
 (b) No Public Distribution. Such Purchaser is acquiring the Shares and the Warrants for its own account, for investment purposes only, and not with a present view towards the public sale or distribution
thereof, except pursuant to a sale or sales that are registered under the Securities Act. Purchaser has not been organized for the purpose of investing in securities of the Company, although such investment is consistent with its purposes.

  
 (c) Subsequent offers and Sales. All subsequent offers
and sales of the Shares, and/or the shares of Common Stock underlying the Warrants, by such Purchaser shall be made pursuant to an effective registration statement under the Securities Act or pursuant to an applicable exemption from such
registration; with any offers and sales which are being made pursuant to an applicable exemption from registration being accompanied by a legal opinion obtained by the selling Purchaser, which legal opinion being satisfactory to the Company and the
Company’s legal counsel. 
  
 (d) Accuracy of
Purchaser’s Representations and Warranties. Such Purchaser understands that the Shares and Warrants are being offered and sold to it in reliance upon exemptions from the registration requirements of the United States federal securities
laws, and that the Company is relying upon the truth and accuracy of such Purchaser’s representations and warranties contained in the Transaction Documents and any ancillary documents thereto, as applicable, and such Purchaser’s compliance
with the Transaction Documents and any ancillary documents thereto, in order to determine the availability of such exemptions and the eligibility of the Purchaser to acquire the Shares and the Warrants in accordance with the terms and provisions of
the Transaction Documents. 
  
 (e) Public Filings. Such
Purchaser: (i) has been provided with all requested information concerning the business of the Company, including, without limitation, the Company’s Annual Report on Form 10-K for the period ended March 31, 2003, Quarterly Report 

 on Form 10-Q for the period ended March 31, 2003; all prior quarterly and annual reports of the Company as has been
requested by the Purchaser; and (ii) has had all requested access to the management of the Company and has had the opportunity to ask questions of the management of the Company. 
  
 (f) Capacity and Authority. Such Purchaser has the requisite capacity and authority to execute, deliver and perform
each of the Transaction Documents and any an all ancillary documents thereto and to consummate the transactions contemplated thereby. Each of the Transaction Documents have been duly executed and delivered by the Purchaser and is a valid and binding
obligation of each of the Purchasers, enforceable against each of the Purchasers in accordance with their terms. 
  
 (g) Due Execution. This Agreement and the other Transaction Documents, and any ancillary documents thereto and the transactions contemplated hereby
and thereby have been duly and validly authorized by the Purchaser and such agreements, when executed and delivered by each of the other parties thereto will each be a valid and binding agreement of such Purchaser, enforceable against such Purchaser
in accordance with their respective terms, except to the extent that enforcement of such agreements may be limited by bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other similar laws now or hereafter in effect relating
to creditors’ rights generally and to general principles of equity. 
  
 (h) Brokers. The Purchasers have not employed, engaged or retained, or otherwise incurred any liability to, any person as a broker, finder, agent or other intermediary in connection with the transactions
contemplated herein. 
  
 3.    REPRESENTATIONS OF THE
COMPANY 
  
 The Company represents and warrants to each
of the Purchasers that: 
  
 (a) Organization. The Company
is a corporation duly organized and validly existing under the laws of the State of Delaware. Each of the Company’s subsidiaries is a corporation duly organized and validly existing under the laws of its respective jurisdiction of
incorporation. Each of the Company and its subsidiaries is duly qualified as a foreign corporation in all jurisdictions in which the failure to so qualify would have a Material Adverse Effect on the Company (as hereinafter defined). All of the
outstanding capital stock of the Company’s subsidiaries is owned either directly or indirectly by the Company. The Company and its subsidiaries have all requisite corporate power and authority, and hold all licenses, permits and other required
authorizations from governmental authorities, necessary to conduct their business as it is now being conducted or proposed to be conducted and to own or lease their properties and assets as they are now owned or held under lease. 
  
 (b) Capitalization. On the date hereof, the authorized capital of the
Company consists of 200,000,000 shares of Common Stock and 10,000,000 shares of preferred stock, par value $.02 per share (“Preferred Stock”). As of May 14, 2003 there were 96,620,858 shares of Common Stock issued and outstanding
and no shares of Preferred Stock issued or outstanding. Schedule 3(b) sets forth all of the options, warrants and convertible securities of the Company, and any other rights to acquire securities of the Company (collectively, the
“Derivative 

 Securities”) which are outstanding on the date hereof, including in each case: (i) the name and class of such
Derivative Securities; and (ii) the number of shares of Common Stock into which such Derivative Securities are convertible as of the date hereof. All outstanding securities of the Company are validly issued, fully paid and nonassessable. No
stockholder of the Company is entitled to any preemptive rights with respect to the purchase of or sale of any securities by the Company. Except as contemplated herein, none of the shares of capital stock of the Company are reserved for any purpose,
other than the issuance upon exercise or conversion of the Derivative Securities, and the Company is neither subject to any obligation (contingent or otherwise), nor has any option, to repurchase or otherwise acquire or retire any shares of its
capital stock. 
  
 (c) Issuance of the Shares. The Shares
are duly authorized and, when issued for the Purchase Price, will be duly and validly issued, fully paid and non-assessable, will be free and clear of any liens imposed by or through the Company, will not be subject to preemptive rights and will not
subject the holder thereof to personal liability by reason of being such a holder. There are currently no preemptive rights of any stockholder of the Company to acquire the Shares. The Shares underlying the Warrants are duly authorized and reserved
for by the Company. 
  
 (d) Reporting Company Status. The
Common Stock is registered under Section 12 of the Exchange Act. The Company files reports with the Commission pursuant to Section 12 and/or 15(d) of the Exchange Act. To the knowledge of the Company, the Company has duly filed all materials and
documents required to be filed pursuant to all reporting obligations under either Section 13(a) or 15(d) of the Exchange Act. The Common Stock is listed and traded on The Nasdaq SmallCap Stock Market (“Nasdaq”). 
  
 (e) Legality. The Company has the requisite corporate power and
authority to enter into each of the Transaction Documents and to issue and deliver the Shares and the Warrants. 
  
 (f) Due Execution. The Transaction Documents, and the transactions contemplated thereby, have been duly and validly authorized by the Company; the
Transaction Documents have been duly executed and delivered by the Company and are each the legal, valid and binding agreement and obligation of the Company, enforceable in accordance with their respective terms, except to the extent that
enforcement of such agreement may be limited by bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other similar laws now or hereafter in effect relating to creditors’ rights generally and to general principles of
equity. 
  
 (g) Non-contravention. The execution and
delivery of the Transaction Documents, and the consummation by the Company of the transactions contemplated thereby, does not (i) result in a violation of either the Certificate of Incorporation or By-laws of the Company, or (ii) constitute a
default under (or an event which with notice or lapse of time or both could become a default) or give to others any rights of termination, amendment or cancellation of, any material agreement, indenture or instrument to which the Company is a party,
or result in a violation of any law, rule, regulation, order, judgment or decree (foreign or domestic and including federal and state securities laws and regulations) applicable to the Company or by which any material property or asset of the
Company is bound or affected other than any of the foregoing which 

 would not have a Material Adverse Effect (as hereinafter defined). Except as set forth in Schedule 3(g), neither
the filing of the registration statement required to be filed by the Company pursuant to the Registration Rights Agreement nor the offering or sale of the Shares, or shares underlying the Warrants, as contemplated by this Agreement gives rise to any
rights, other than those which have been waived or satisfied on or prior to the date hereof, for or relating to the registration of any shares of the Common Stock. 
  
 (h) Approvals. Other than the filing of a Registration Statement with the Securities and Exchange Commission (the
“SEC”), as contemplated by the Registration Rights Agreement, and the receipt by the Company of approval from the SEC for such Registration Statement to be declared effective, no authorization, approval or consent of any court,
governmental body, regulatory agency, self-regulatory organization, stock exchange or market or the stockholders of the Company is required to be obtained by the Company for the entry into or the performance of the Transaction Documents. 

 
 (i) SEC Documents, Financial Statements. Since September 1, 2002,
the Company has filed all reports, schedules, forms and statements required to be filed by it with the Commission pursuant to the reporting requirements of the Exchange Act (hereinafter, the “SEC Documents”). As of their respective
dates, none of the SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. The financial statements of the Company included in the SEC Documents were prepared in accordance with U.S. generally accepted accounting principles, consistently applied, during the periods involved (except (i) as may be
otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited interim statements, to the extent they may not include footnotes or year end accounting or audit adjustments or may be condensed or summary
statements) and fairly present in all material respects the consolidated financial position of the Company and its consolidated subsidiaries and results of their operations and cash flows for the periods covered thereby (subject, in the case of
unaudited statements, to normal year-end audit adjustments). 
  
 (j) Undisclosed Liabilities. The Company has no material obligation or liability (whether accrued, absolute, contingent, unliquidated, or otherwise, whether due or to become due) arising out of transactions entered into at or prior
to the Closing of this Agreement, or any action or inaction at or prior to the Closing of this Agreement, or any state of facts existing at or prior to the Closing of this Agreement, except (a) liabilities described in or reflected on the latest
balance sheet included in the SEC Documents (the “Company Balance Sheet”), and (b) liabilities incurred in the ordinary course of business since the date of the Company Balance Sheet. 
  
 (k) Absence of Certain Changes. Except as disclosed in the SEC
Documents, since March 31, 2003, there has been no material adverse change in the business, properties, operations, financial condition or results of operations of the Company and its subsidiaries, taken as a whole (each, a “Material Adverse
Effect”). 
  
 (l) Insurance. The Company and its
subsidiaries maintain property and casualty, general liability, personal injury and other similar types of insurance that are reasonably adequate 

 and consistent with industry standards and historical claims experience. The Company and its subsidiaries have not
received notice from, and have no knowledge of any threat by, any insurer (that has issued any insurance policy to the Company or its subsidiaries) that such insurer intends to deny coverage under or cancel, discontinue or not renew any insurance
policy covering the Company or any of its subsidiaries presently in force. 
  
 (m) Compliance with Law. To the knowledge of the Company, the Company and its subsidiaries have complied in all material respects with all applicable statutes and regulations of the United States and of all
states, municipalities and applicable agencies and foreign jurisdictions or bodies in respect of the conduct of its business and operations, and the failure, if any, by the Company or its subsidiaries to have fully complied with any such statute or
regulation has not resulted in a Material Adverse Effect. 
  
 (n) Brokerage Fees. Except as set forth on Schedule 3(n), the Company and its subsidiaries have not incurred any liability for any consulting fees or agent’s commissions in connection with the offer and sale of the Shares
and the transactions contemplated by this Agreement. 
  
 4.    CERTAIN COVENANTS AND ACKNOWLEDGMENTS 
  
 (a) (a) Transfer Restrictions. Each of the Purchasers acknowledges that, except as provided in the Registration Rights Agreement, (i) none of the Shares or the Shares underlying Warrants have been, or are
being, registered under the Securities Act, and such securities may not be transferred unless (A) subsequently registered thereunder or (B) they are transferred pursuant to an exemption from such registration; and (ii) any sale of the Shares or the
Shares underlying Warrants made in reliance upon Rule 144 under the Securities Act may be made only in accordance with the terms of said Rule, accompanied by a legal opinion obtained by the Purchasers which is satisfactory to the Company’s
legal counsel. The provisions of Section 4(a) and 4(b) hereof, together with the rights and obligations of the Purchasers under the Transaction Documents, shall be binding upon any subsequent transferees of the Shares or the Shares underlying
Warrants. 
  
 (b) Restrictive Legend. Each of the
Purchasers acknowledges and agrees that, until such time as the Shares shall have been registered under the Securities Act or such Purchaser demonstrates to the reasonable satisfaction of the Company and its legal counsel that such registration
shall no longer be required, such Shares and Warrants shall bear a restrictive legend in substantially the following form: 
  
 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR
OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER SAID ACT OR AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO 

 THE COMPANY THAT SUCH REGISTRATION SHALL NO LONGER BE REQUIRED. 
  
 (c) Filings. The Company undertakes and agrees that it will make all
required filings in connection with the sale of such Shares and Warrants to the Purchasers, as required by United States laws and regulations, or by any domestic securities exchange or trading market, and if applicable, the filing of a notice on
Form D (at such time and in such manner as required by the Rules and Regulations of the Commission), and to provide copies thereof to the Purchasers promptly after such filing or filings. 
  
 (d) NASDAQ Listing. The Company shall use reasonable efforts to promptly secure the listing of the Shares, and the
Shares underlying the Warrants upon each national securities exchange or automated quotation system, if any, upon which the Common Stock is then listed. The Company further agrees and covenants that it will not seek to have the trading of its Common
Stock on Nasdaq suspended or terminated, will use reasonable efforts to maintain its eligibility for trading on Nasdaq and, if such trading of its Common Stock is suspended or terminated, will use reasonable efforts to requalify its Common Stock or
otherwise cause such trading to resume. 
  
 (e) Reporting
Status. The Company shall timely file, or timely obtain extensions of time to file, all reports required to be filed with the Commission pursuant to Section 13 or 15(d) of the Exchange Act and shall not terminate its status as an issuer required
to file reports under the Exchange Act even if the Exchange Act or the rules and regulations thereunder would permit such termination. 
  
 (f) State Securities Filings. The Company shall from time to time promptly take such action as either the Purchasers or any of their
representatives, if applicable, may reasonably request to qualify the Shares, and the Shares underlying the Warrants, if applicable, for offering and sale under the securities laws (other than United States federal securities laws) of the
jurisdictions in the United States as shall be so identified to the Company, and to comply with such laws so as to permit the continuance of sales therein, except that the Company shall not for any such purpose be required to qualify generally to do
business as a foreign corporation in any jurisdiction wherein it would not but for the requirements of this subsection (f) be obligated to be so qualified, or to subject itself to taxation in any such jurisdiction, or to consent to general service
of process in any such jurisdiction. 
  
 5.    TRANSFER
AGENT INSTRUCTIONS 
  
 The Company warrants that no
instruction, other than the instructions referred to in this Section 5, prior to the registration and sale under the Securities Act of the Common Stock will be given by the Company to its transfer agent in respect of the Shares and that the Shares
shall otherwise be freely transferable on the books and records of the Company as and to the extent provided in this Agreement, the Registration Rights Agreement and applicable law. Nothing in this Section shall affect in any way the
Purchasers’ obligations and agreement to comply with all applicable securities laws upon resale of the Shares. If a Purchaser provides the Company with an opinion of counsel reasonably satisfactory to the Company and its legal counsel that

 registration of a resale by the Purchaser of any of the Shares in accordance with Section 4(a) of this Agreement is not
required under the Securities Act, the Company shall permit the transfer of the Shares and promptly instruct the Company’s transfer agent to issue one or more certificates for Common Stock without legend in such names and in such denominations
as specified by the Purchaser. 
  

	6.	 	CONDITIONS TO THE COMPANY’S OBLIGATION TO ISSUE THE SHARES AND THE WARRANTS 

  
 Each Purchaser understands that the Company’s obligation to issue the Shares and the Warrants on the Closing Date to
the Purchasers pursuant to this Agreement is conditioned upon the satisfaction by the Purchasers or the waiver by the Company of each of the following conditions: 
  
 (a) The accuracy on the Closing Date of the representations and warranties of the Purchasers contained in this Agreement, as
if made on the Closing Date, and the performance by the Purchasers, on or before the Closing Date, of all covenants and agreements of the Purchasers required to be performed on or before the Closing Date. 
  
 (b) The absence or inapplicability of any and all laws, rules or regulations
prohibiting or restricting the transactions contemplated hereby, or requiring any consent or approval which shall not have been obtained. 
  
 (c) The Purchasers shall have executed each of the Transaction Documents and any and all ancillary documents thereto and delivered the same to the
Company. 
  
 (d) The Purchasers shall have delivered the full
Purchase Price in accordance with Section 1(a) above. 
  
 (g) The
Company shall have received from the Purchasers such other certificates and documents as they or their representatives, if applicable, shall reasonably request, and all proceedings taken by the Purchasers in connection with the Transaction Documents
contemplated by this Agreement and the other Transaction Documents and all documents and papers relating to such Transaction Documents shall be satisfactory to the Company. 
  

	7.	 	CONDITIONS TO THE PURCHASERS’ OBLIGATION TO PURCHASE THE SHARES AND THE WARRANTS 

  
 The Company understands that the Purchasers’ obligation to purchase the Shares and the Warrants on the Closing Date is
conditioned upon the satisfaction by the Company or the waiver by the Purchasers of each of the following conditions: 
  
 (a) The accuracy on the Closing Date of the representations and warranties of the Company contained in this Agreement as if made on the Closing Date, and
the performance by the Company, on or before the Closing Date, of all covenants and agreements of the Company 

 required to be performed on or before the Closing Date. 
  
 (b) The Company shall have executed the Transaction Documents and any and all ancillary documents thereto and delivered same
to the Purchasers. 
  
 (c) On the Closing Date, the Purchasers
shall have received an opinion of counsel for the Company, dated the Closing Date. 
  
 (d) On the Closing Date, the Purchasers shall have received a certificate executed by the President or the Chief Executive Officer of the Company and by the Chief Financial Officer of the Company, stating that all of
the representations and warranties of the Company set forth in the Transaction Documents are accurate as of the Closing Date and that the Company has performed all of its covenants and agreements required to be performed under the Transaction
Documents on or before the Closing Date. 
  
 (e) The Purchasers
shall have received an incumbency certificate, dated the Closing Date, for the officers of the Company executing this Agreement, and any other documents or instruments delivered in connection with the Transaction Documents at the Closing.

  
 (f) The Purchasers shall have received a certificate of the
Secretary of the Company, dated the Closing Date, as to the continued and valid existence of the Company, certifying the attached copy of the By-laws of the Company, the authorization of the execution, delivery and performance of the Transaction
Documents, and the resolutions adopted by the Board of Directors of the Company authorizing the actions to be taken by the Company contemplated by the Transaction Documents. 
  
 (g) The Purchasers shall have received from the Company such other certificates and documents as they or their
representatives, if applicable, shall reasonably request, and all proceedings taken by the Company in connection with the Transaction Documents contemplated by this Agreement and the other Transaction Documents and all documents and papers relating
to such Transaction Documents shall be satisfactory to the Purchasers. 
  
 (h) No injunction, order, investigation, claim, action or proceeding before any court or governmental body shall be pending or threatened wherein an unfavorable judgment, decree or order would restrain, impair or prevent the carrying out of
this Agreement or the other Transaction Documents or any of the transactions contemplated hereby or thereby, declare unlawful the transactions contemplated by this Agreement or the other Transaction Documents or cause any such transaction to be
rescinded. 
  
 (i) The Company shall have obtained in writing or
made all consents, waivers, approvals, orders, permits, licenses and authorizations of, any registrations, declarations, notices to and filings and applications with, any governmental authority or any other person or entity (including, without
limitation, securityholders and creditors of the Company) required to be obtained or made in order to enable the Company to observe and comply with all its obligations under this Agreement or the other Transaction Documents and to consummate the
transactions contemplated hereby and thereby. 

 8.    INDEMNIFICATION 
  
 (a) Indemnification of Purchasers by the Company. 
  
 The Company hereby agrees to indemnify and hold harmless each of the Purchasers, their affiliates and their respective
officers, managers, members, directors, partners, shareholders, employees and members (collectively, the “Buyer Indemnitees”), from and against any and all losses, claims, damages, judgments, penalties, liabilities and deficiencies
(collectively, “Losses”), and agrees to reimburse the Buyer Indemnitees for all out-of-pocket expenses (including the fees and expenses of legal counsel), in each case promptly as incurred by the Buyer Indemnitees and to the extent
arising out of or in connection with: 
  

	 	(i)	 	a material misrepresentation, omission of fact or breach of any of the Company’s representations, warranties or covenants contained in this Agreement, the annexes, schedules or
exhibits hereto or any instrument, agreement or certificate entered into or delivered by the Company pursuant to this Agreement; or 

  

	 	(ii)	 	a material failure by the Company to perform any of its covenants, agreements, undertakings or obligations set forth in this Agreement, the annexes, schedules or exhibits hereto or
any instrument, agreement or certificate entered into or delivered by the Company pursuant to this Agreement. 

  
 (b) Indemnification of the Company by Purchasers. 
  
 Each of the Purchasers hereby severally agrees to indemnify and hold harmless the Company, its affiliates and their respective officers, directors,
partners and members (collectively, the “Company Indemnitees”), from and against any and all Losses, and agrees to reimburse the Company Indemnitees for all out-of-pocket expenses (including the reasonable fees and expenses of legal
counsel), to the extent arising out of or in connection with any breach of any of such Purchaser’s representations, warranties or covenants contained in this Agreement, the annexes, schedules or exhibits hereto or any instrument, agreement or
certificate entered into or delivered by such Purchaser pursuant to this Agreement. 
  
 (c) Third Party Claims. 
  
 Promptly after receipt by either party hereto seeking indemnification pursuant to this Section 8 (an “Indemnified Party”) of written notice of any investigation, claim, proceeding or other action in respect of which
indemnification is being sought (each, a “Claim”), the Indemnified Party promptly shall notify the party against whom indemnification pursuant to this Section 8 is being sought (the “Indemnifying Party”) of the
commencement thereof; but the omission to so notify the Indemnifying Party shall not relieve it from any liability that it otherwise may have to the Indemnified Party, except to the extent that the Indemnifying Party is materially prejudiced and
forfeits substantive rights and defenses by reason of such failure. In 

 connection with any Claim as to which both the Indemnifying Party and the Indemnified Party are parties, the Indemnifying
Party shall be entitled to assume the defense thereof. Notwithstanding the assumption of the defense of any Claim by the Indemnifying Party, the Indemnified Party shall have the right to employ separate legal counsel and to participate in the
defense of such Claim, and the Indemnifying Party shall bear the reasonable fees, out-of-pocket costs and expenses of such separate legal counsel to the Indemnified Party if (and only if): (x) the Indemnifying Party shall have agreed to pay such
fees, out-of-pocket costs and expenses, (y) the Indemnified Party and the Indemnifying Party reasonably shall have concluded that representation of the Indemnified Party by the Indemnifying Party by the same legal counsel would not be appropriate
due to actual or, as reasonably determined by legal counsel to the Indemnified Party, potentially differing interests between such parties in the conduct of the defense of such Claim, or if there may be legal defenses available to the Indemnified
Party that are in addition to or disparate from those available to the Indemnifying Party, or (z) the Indemnifying Party shall have failed to employ legal counsel reasonably satisfactory to the Indemnified Party within a reasonable period of time
after notice of the commencement of such Claim. If the Indemnified Party employs separate legal counsel in circumstances other than as described in clauses (x), (y) or (z) above, the fees, costs and expenses of such legal counsel shall be borne
exclusively by the Indemnified Party. Except as provided above, the Indemnifying Party shall not, in connection with any Claim in the same jurisdiction, be liable for the fees and expenses of more than one firm of legal counsel for the Indemnified
Party (together with appropriate local counsel). The Indemnifying Party shall not, without the prior written consent of the Indemnified Party (which consent shall not unreasonably be withheld) settle or compromise any Claim or consent to the entry
of any judgment that does not include an unconditional release of the Indemnified Party from all liabilities with respect to such Claim or judgment. 
  
 (d) Notwithstanding anything to the contrary in this Agreement, the aggregate payments for indemnification (including the reasonable fees and expenses of
legal counsel) made by the Company to the Purchaser pursuant to this Section 9 with respect to any Loss, Claim, or series of Losses or Claims, shall not exceed the Purchase Price. 
  
 (e) Notwithstanding Section 13(b) of this Agreement, the indemnification described in Section 9 shall be the sole and
exclusive remedy for any inaccuracy or breach of any representation or warranty, condition, or covenant made in this Agreement or in the Transaction Documents. 
  

9.    EXPENSES 
  
 (a) The Company covenants and agrees with the Purchasers that the Company shall pay or cause to be paid the following: (i) all expenses in connection with
registration or qualification of the Shares and the shares underlying the Warrants, for offering and sale under federal securities laws, and state securities laws; and (ii) all other costs and expenses incident to the performance of its obligations
hereunder which are not otherwise specifically provided for in this Section, including the fees and disbursements of the Company’s counsel, accountants and other professional advisors, if any. 

 (b) Other than as set forth in Section 10(a) above, each of the parties hereto agree that they shall each
be responsible for and pay their own expenses and fees, including all legal, accounting and other professional fees, associated with the transactions contemplated by Transaction Documents. 
  
 10.    SURVIVAL 
  
 The representations and warranties of the Company and the Purchasers shall
survive the Closing for a period of one year and thereafter shall be of no force or effect. The agreements and covenants of the Company and the Purchasers, including indemnification obligations under Section 9, shall survive the execution and
delivery of this Agreement and the delivery of the Shares hereunder until the Company has satisfied in full its obligations under the terms of the Registration Rights Agreement; provided that, any claim for indemnification for a breach of a
representation or warranty must be made prior to the first anniversary of the Closing Date. 
  
 11.    MISCELLANEOUS 
  
 (a) Governing Law; Jurisdiction. This Agreement shall be governed by and interpreted in accordance with the internal laws of the State of New York, without giving effect to conflicts of laws issues. Each of the
parties submits to the jurisdiction of the federal courts whose districts encompass any part of the City of New York or the state courts of the State of New York sitting in the City of New York in connection with any dispute arising under this
Agreement or any of the transactions contemplated hereby, and hereby waives, to the maximum extent permitted by law, any objection, including any objections based on forum non conveniens, to the bringing of any such proceeding in such
jurisdictions. 
  
 (b) Counterparts. This Agreement may be
signed in two or more counterparts, each of which shall be deemed an original. 
  
 (c) Headings. The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation of, this Agreement. 
  
 (d) Severability. If any provision of this Agreement shall be invalid
or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of the remainder of this Agreement or the validity or unenforceability of this Agreement in any other jurisdiction. 

 
 (e) Successors. This Agreement shall inure to the benefit of, and
be binding upon the successors and assigns of each of the parties hereto. 
  
 (f) Amendments. This Agreement may be amended only by an instrument in writing signed by the parties hereto. 
  
 (g) Merger. This Agreement, together with the other Transaction Documents, 

 supersedes all prior agreements and understandings among the parties hereto with respect to the subject matter hereof.

  
 (h) Notices. Any notice required or permitted hereunder
shall be given in writing (unless otherwise specified herein) and shall be effective upon personal delivery, via facsimile (upon receipt of confirmation of error-free transmission) or two business days following deposit of such notice with an
internationally recognized courier service, with postage prepaid and addressed to each of the other parties thereunto entitled at the following addresses, or at such other addresses as a party may designate by five days advance written notice to
each of the other parties hereto. 
  

	Company:	  	 Acclaim Entertainment, Inc.
 One Acclaim Plaza
 Glen Cove, New York 11542
 ATTENTION:    Gerard
Agoglia
                             Chief Financial Officer

	 	  	 Tel.:
	  	 (516) 656-5000

	 	  	 Fax:
	  	 (516) 656-2039

		
	 	  	 with a copy to:
  
 Acclaim Entertainment, Inc.
 One Acclaim Plaza
 Glen Cove, New York 11542
 ATTENTION:    Edward M.
Slezak
                             Vice President, Corporate Counsel

	 	  	 Tel.:
	  	 (516) 656-5000

	 	  	 Fax:
	  	 (516) 656-2045

		
	Purchasers:	  	 [Insert Contact Information as per Purchasers]

  
 12.    NON-DISCLOSURE. 
  
 (a) The Purchasers acknowledge that the Company is a publicly-listed company and, as such, is subject to strict regulation governing the disclosure of information relating to corporate transactions. Except as required by law, without the
prior written consent of the Company, the Purchasers will not directly or indirectly, make any public comment, statement or communication to any individual or entity with respect to, or otherwise disclose the existence of discussions regarding a
possible transaction between the parties or any of the terms, conditions, or other aspects of this Agreement until such time as the transaction is completed, or any confidential information provided by the Company to the Purchasers. Further, the
Purchasers acknowledge that they may not trade in the securities of the Company when they are in possession of material, non-public information and that they agree that they will not do so. The Purchasers will not use any confidential information
provided by Company to the Purchasers for any purpose other than evaluating an investment by the Purchasers in the Shares. Confidential 

 Information shall include all non-public information provided by the Company to the Purchasers, but shall not include
information that (a) is now or subsequently becomes generally available to the public through no wrongful act or omission of the Purchasers, (b) the Purchasers can demonstrate to have had rightfully in their possession prior to disclosure to the
Purchasers by the Company, and (c) the Purchasers rightfully obtain from a third party who has the right to transfer or disclose it. If the Purchasers are required by law, based on an opinion provided by the Purchasers’ counsel, to make any
such disclosure, they shall first provide to the Company the content of the proposed disclosure, the reasons that such disclosure is required by law, and the time and place that the disclosure will be made. 
  
 (b) The Company and the Purchasers each recognize that in the event that any
party fails to perform, observe, or discharge any or all of its obligations under this Section 13, any remedy at law may prove to be inadequate relief to the aggrieved party. The Company and the Purchasers therefore agree that an aggrieved party
under this Section 13, if such party so requests, shall be entitled to temporary and permanent injunctive relief in any such case without the necessity of proving actual damages. 
  
 IN WITNESS WHEREOF, this Investment Agreement has been duly executed by each of the undersigned. 
  

	 COMPANY:
  
 ACCLAIM ENTERTAINMENT, INC.

		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 

  

	PURCHASER:
		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 

  

	PURCHASER:
		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 

 SCHEDULE 1 
  

	 Name of Purchaser

	 	 Number of Shares

	 	 Dollar Amount

 SCHEDULE 3(b) 
  
 Outstanding Derivative Securities and Related Registration Rights 

 Schedule 3(g) 

 Schedule 3(n)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00054-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00054-of-00352.parquet"}]]